B
Bionano Genomics, Inc. (BNGO)
NCM – Real Time Price. Currency in USD
1.26
-0.01 (-0.79%)
At close: May 12, 2026, 4:00 PM EDT
1.29
+0.03 (2.56%)
After-hours: May 12, 2026, 7:33 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.26
-0.01 (-0.79%)
At close: May 12, 2026, 4:00 PM EDT
1.29
+0.03 (2.56%)
After-hours: May 12, 2026, 7:33 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.98 | 3.39 | 9.0 | |
| Quick ratio | 1.64 | 2.51 | 8.0 | |
| Debt to Equity | 0.38 | 0.29 | 7.0 | |
| Debt to Assets | 0.23 | 0.62 | 7.0 | |
| Interest coverage | -118.56 | 24.85 | 1.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 28M | 36M | 31M | 29M | 29M |
| Gross Profit | -3M | 10M | -11M | 6M | 13M |
| Operating Income | -130M | -139M | -86M | -33M | -33M |
| Net Income | -133M | -232M | -112M | -26M | -26M |
| EBITDA | -119M | -126M | -71M | -24M | -24M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 1.71 | 23.48 | 6.5 |
| Next quarter | 11.69 | 60.25 | 8.5 |
| Current year | 12.73 | 60.03 | 9.0 |
| Next year | 34.74 | 57.31 | 10 |
| Weighted average score | 8.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 7.93 | 6.7 | 24.02 | 29.46 | 7.8 |
| Y/Y | -2.59 | 60.58 | 87.23 | 38.67 | 7.8 |
| 3y average | 2.59 | 17.64 | 41.01 | 40.14 | 8.3 |
| 5y average | 34.77 | -21.25 | 15.89 | -9.1 | 5.3 |
| Weighted average score | 7.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $16.9M significantly exceeds cash reserves ($13.3M), raising financial stability concerns
Total current assets $45.4M exceed Total current liabilities $22.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-118.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.2M limits the company's ability to reinvest or pay down debt